Bio-Path Holdings received a notice from Nasdaq for not meeting the minimum bid price requirement of $1.00 per share, giving them until June 10, 2025, to regain compliance, while also approving an amendment to increase shares under their stock incentive plan by 1.2 million shares and a potential reverse stock split of up to 1-for-30.